JY
ROIV icon

Jeff Yass’s Roivant Sciences ROIV Stock Holding History

Jeff Yass’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46M Buy
1,301,013
+1,104,818
+563% +$32.6M ﹤0.01% 1594
2026
Q1 		$5.43M Sell
196,195
-1,090,002
-85% -$28M ﹤0.01% 4087
2025
Q4 		$27.9M Buy
1,286,197
+827,608
+180% +$16.3M ﹤0.01% 1882
2025
Q3 		$6.94M Buy
458,589
+324,882
+243% +$4.02M ﹤0.01% 3574
2025
Q2 		$1.51M Sell
133,707
-127,351
-49% -$1.38M ﹤0.01% 6434
2025
Q1 		$2.63M Buy
261,058
+134,271
+106% +$1.45M ﹤0.01% 4928
2024
Q4 		$1.5M Sell
126,787
-183,220
-59% -$2.17M ﹤0.01% 5954
2024
Q3 		$3.58M Buy
310,007
+15,582
+5% +$177K ﹤0.01% 4218
2024
Q2 		$3.11M Sell
294,425
-309,637
-51% -$3.39M ﹤0.01% 4235
2024
Q1 		$6.37M Buy
+604,062
New +$6.51M ﹤0.01% 3242
2023
Q4 		– Sell
-204,056
Closed -$1.99M – 13172
2023
Q3 		$2.38M Buy
204,056
+154,035
+308% +$1.74M ﹤0.01% 4798
2023
Q2 		$504K Sell
50,021
-171,346
-77% -$1.53M ﹤0.01% 8293
2023
Q1 		$1.63M Buy
221,367
+192,946
+679% +$1.59M ﹤0.01% 5589
2022
Q4 		$227K Sell
28,421
-13,992
-33% -$77.8K ﹤0.01% 9803
2022
Q3 		$137K Buy
42,413
+6,118
+17% +$23.7K ﹤0.01% 11368
2022
Q2 		$148K Sell
36,295
-172
-0.5% -$683 ﹤0.01% 11040
2022
Q1 		$180K Buy
36,467
+25,724
+239% +$170K ﹤0.01% 11370
2021
Q4 		$108K Buy
+10,743
New +$89.4K ﹤0.01% 12091

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Jeff Yass's ROIV Position: Q2 2026 in Review

Jeff Yass increased its Roivant Sciences (ROIV) stake by 563% in Q2 2026, buying an estimated $32.6M and bringing the position to 1,301,013 shares worth $46M. The position accounts for ﹤0.01% of the portfolio, ranked #1594.

Jeff Yass first reported a position in ROIV in Q4 2021 and has held it in 18 quarters since. 496 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Jeff Yass held 1,301,013 shares of Roivant Sciences worth $46M as of Q2 2026.
  • Jeff Yass bought 1,104,818 Roivant Sciences shares in Q2 2026, an estimated $32.6M.
  • Roivant Sciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #1594 holding.
  • Jeff Yass first reported a position in Roivant Sciences in Q4 2021 and has held it in 18 quarters since.
  • 496 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.